Testosterone replacement therapy (TRT) is a medical treatment that restores testosterone levels in men diagnosed with clinically low testosterone, also called hypogonadism. The American Urological Association defines low testosterone as levels below 300 nanograms per deciliter (ng/dL), affecting approximately 4-5 million men in the United States. TRT involves administering synthetic or bioidentical testosterone through injections, gels, patches, or pellets to bring hormone levels back to a normal range of 300-1,000 ng/dL. Clinical studies show that properly administered TRT can improve energy levels, muscle mass, bone density, and sexual function in men with confirmed testosterone deficiency. The treatment requires ongoing medical supervision, regular blood monitoring, and careful dosage adjustments. As of 2026, TRT costs typically range from $150-400 per month depending on the delivery method and insurance coverage.
Key Takeaways
- TRT treats clinically diagnosed low testosterone (below 300 ng/dL) in men
- Available delivery methods include injections, gels, patches, and pellets
- Treatment requires medical supervision and regular blood testing
- Monthly costs in 2026 range from $150-400 depending on method and coverage
- Clinical benefits include improved energy, muscle mass, and sexual function
Who Needs Testosterone Replacement Therapy
Men with testosterone levels below 300 ng/dL who experience symptoms of hypogonadism are candidates for TRT. The Endocrine Society recommends testosterone testing for men over 40 who report fatigue, decreased libido, erectile dysfunction, loss of muscle mass, or mood changes. Primary hypogonadism occurs when the testicles don't produce enough testosterone, while secondary hypogonadism results from problems with the pituitary gland or hypothalamus. Approximately 39% of men over age 45 have testosterone levels below 300 ng/dL according to recent population studies. However, diagnosis requires both low testosterone levels confirmed by two morning blood tests and the presence of clinical symptoms. Age-related testosterone decline typically begins around age 30, with levels dropping 1-2% annually.Types of TRT Treatment Methods
Testosterone injections remain the most common and cost-effective TRT delivery method, typically administered every 1-2 weeks at doses of 100-200mg. Intramuscular injections of testosterone cypionate or enanthate provide steady hormone levels but may cause fluctuations between doses. Topical testosterone gels, applied daily to the shoulders or abdomen, offer more consistent levels but carry risks of transfer to family members. Testosterone patches deliver 2-6mg daily through the skin but may cause irritation in up to 37% of users. Subcutaneous testosterone pellets, implanted every 3-4 months, provide the most stable levels but require minor surgical procedures. Many patients also explore complementary treatments like peptide therapy options, including Sermorelin for natural growth hormone support.Benefits and Risks of TRT
Clinical studies demonstrate that TRT can increase lean body mass by 1.9-4.2 kg within 6-12 months when testosterone levels are restored to normal ranges. Men typically report improved energy levels, enhanced mood, better sexual function, and increased bone density after 3-6 months of treatment. However, TRT carries potential risks including increased red blood cell count (polycythemia) in 13-a notable portion of patients, which requires monitoring. The therapy may worsen sleep apnea, cause acne or hair loss, and potentially affect cardiovascular health in some men. Prostate monitoring is essential, as TRT is contraindicated in men with prostate cancer. Some patients combine TRT with supportive therapies like BPC-157 for tissue healing or Ipamorelin for additional growth hormone benefits.Cost and Accessibility in 2026
TRT costs vary significantly based on delivery method and insurance coverage in 2026. Generic testosterone injections typically cost $30-60 per month, while brand-name gels range from $200-400 monthly. Many insurance plans cover TRT for clinically diagnosed hypogonadism, reducing out-of-pocket costs to $20-50 monthly copays. Telemedicine platforms have expanded access, with detailed TRT programs including monitoring costing $150-300 monthly. Some patients explore additional peptide options like TB-500 for enhanced recovery benefits. Initial consultation and laboratory work typically cost $200-500, with ongoing monitoring requiring quarterly blood tests costing $100-200 each.Frequently Asked Questions
How long does it take to see results from TRT?
Most men notice initial improvements in energy and mood within 2-4 weeks of starting TRT. Sexual function typically improves within 4-6 weeks, while changes in muscle mass and bone density become apparent after 3-6 months of consistent treatment. Peak benefits usually occur after 6-12 months when testosterone levels stabilize in the normal range : real differences.
Check if TRT is right for you
Take a free 2-minute assessment to see if testosterone replacement therapy could help restore your energy, mood, and vitality.
Start Free Assessment →View data table
| Category | Patients Reporting Improvement (%) | Detail |
|---|---|---|
| Energy | 78 | Improves in 2-4 weeks |
| Mood | 72 | Stabilizes in 4-6 weeks |
| Libido | 82 | Returns in 3-6 weeks |
| Muscle | 65 | Visible at 3-4 months |
| Body Fat | 58 | Reduces over 6+ months |
Is TRT safe for long-term use?
TRT appears safe for long-term use in men with clinically diagnosed hypogonadism when properly monitored by healthcare providers. Regular blood testing every 3-6 months helps detect potential side effects like elevated red blood cell counts. The key is maintaining testosterone levels within normal ranges and monitoring prostate health, cardiovascular markers, and overall wellness.
Can I stop TRT once I start?
Yes, you can discontinue TRT, but testosterone levels will return to pre-treatment ranges within several weeks to months. Men with primary hypogonadism will likely need lifelong treatment, while those with secondary causes might recover natural production after addressing underlying issues. Gradual tapering under medical supervision is recommended rather than abrupt cessation.
Does TRT affect fertility?
TRT can suppress sperm production by reducing luteinizing hormone and follicle-stimulating hormone levels. This effect may be reversible, but recovery can take 6-24 months after stopping treatment. Men planning to father children should discuss alternatives like human chorionic gonadotropin (hCG) or clomiphene citrate with their healthcare provider.
What's the difference between TRT and testosterone boosters?
TRT involves prescription testosterone administered under medical supervision to treat diagnosed hypogonadism. Over-the-counter testosterone boosters contain vitamins, minerals, and herbs that may support natural testosterone production but don't provide actual testosterone. These supplements are not regulated as medications and typically show modest effects compared to prescription TRT.
Sources
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. PMID: 29601923
- Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559. PMID: 20525905
- Corona G, Rastrelli G, Monami M, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytical study. Eur J Endocrinol. 2011;165(5):687-701. PMID: 21852391
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. PMID: 26886521
- Nassar GN, Leslie SW. Physiology, testosterone. StatPearls Publishing. 2023. PMID: 30855827
- Handelsman DJ, Hirschberg AL, Bermon S. Circulating testosterone as the hormonal basis of sex differences in athletic performance. Endocr Rev. 2018;39(5):803-829. PMID: 30010735
- Thirumalai A, Berkseth KE, Amory JK. Treatment of hypogonadism: current and future therapies. F1000Res. 2017;6:68. PMID: 28184288
- Morgentaler A, Miner MM, Caliber M, et al. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015;90(2):224-251. PMID: 25636998
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →